BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31002131)

  • 1. Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.
    Zhang J; Tian ZL; Zhang WT; Cheng LM; Liu J; Cao YX; Zhang ZR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2803-2808. PubMed ID: 31002131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.
    Zhu XP; Wang XL; Ma J; Fang YF; Zhang HJ; Zhang C; Feng MC
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of miR-181d is associated with poor prognosis and tumor progression of gastric cancer.
    Li Z; Guo Q; Lu Y; Tian T
    Cancer Biomark; 2019; 26(3):353-360. PubMed ID: 31524144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
    An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
    Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
    Min C; Zhang A; Qin J
    Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
    Li J; Zou X
    Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.
    Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-1298 expression correlates with prognosis and inhibits cell proliferation and invasion of gastric cancer.
    Qiu ZK; Liu N; Zhao SF; Ding AP; Cheng G; Qiu WS; Qi WW
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1672-1679. PubMed ID: 29630111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
    Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
    Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
    Kong Y; Ning L; Qiu F; Yu Q; Cao B
    Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer.
    Su Z; Zhao J; Rong Z; Geng W; Wang Z
    Int J Clin Exp Pathol; 2015; 8(8):9154-60. PubMed ID: 26464660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells.
    Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G
    Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer.
    Yang Q; Zhang C; Huang B; Li H; Zhang R; Huang Y; Wang J
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):953-7. PubMed ID: 23751352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
    Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
    Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation miR-539 is associated with poor prognosis of gastric cancer patients and aggressive progression of gastric cancer cells.
    Jin W; Han H; Liu D
    Cancer Biomark; 2019; 26(2):183-191. PubMed ID: 31403943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
    Cui Z; Zheng X; Kong D
    World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
    Zhang HP; Sun FB; Li SJ
    Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
    Ma G; Dai W; Sang A; Yang X; Gao C
    Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer.
    Inoue T; Iinuma H; Ogawa E; Inaba T; Fukushima R
    Oncol Rep; 2012 Jun; 27(6):1759-64. PubMed ID: 22407237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.